Venue: Hall 4, 80 Jurong East Street 21, Level 1, Devan Nair Institute for Employment and Employability S(609607)
Course Fee: $25 per participant per seminar (Free for Singaporeans/PRs)
Course fees for Singaporeans/PRs are fully supported by e2i. A fee of $25 applies for other participants, payable to Republic Polytechnic.
Please register at the bottom of this page
10 April 2019, Wed
2pm - 5pm
IoT in Healthcare
For nearly all individuals and families, health and wellbeing are linked to a very dynamic personal and social context – in realtime. To be able to personalize lasting impact, we need to be able to turn context into measurable, quantifiable and traceable data. New sensor technologies allow to translate ‘feelings’ into a digital profile that than can be leveraged to deliver a sustainable impact on the individuals’ health, ideally before any medical symptoms occur.
This session tackles new emerging trends and opportunities in active lifestyles, behavior, nutrition and supplementation, diagnostics and wearables to maximize anyone’s opportunities and live life to the fullest, longest, heathiest.
Dr Bert Grobben, Chief Executive Officer, Budding Innovations
Dr. Bert Grobben, brings 15 years Corporate experience (Procter & Gamble & Avery Dennison), in both B2B and B2C businesses. Rooted in a Life Science background and senior Global R&D leadership roles, he developed a wide global industry network and deep experience in and matching & maturing technology potential based on consumer, customer or specific market needs. He has a successful track record of building and growing businesses by maturing and adopting new technologies. He is an expert in Open Innovation and has developed a refined approach to meet the variables each individual innovation project faces.
Most recently he became a serial venture builder and is the (co-)founder of Budding Innovations, Ecoworth Tech, Athlede and Actualyzed, while having leadership roles in several other technology start-ups.
Dr Lawrence Wee, Chief Data Scientist, Allianz Asia Pacific
Dr. Lawrence Wee is a data science practitioner and innovator in healthcare and insurance. At Allianz Asia-Pacific he provides healthcare data science thought leadership and drives regional innovation efforts at the intersection of data, health and insurance.
Prior to this role, he founded the healthcare and biomedical analytics laboratory at the Institute of Infocomm Research (I2R) in Singapore, and served as principal investigator for research initiatives in genomics, precision medicine, digital health and population health. After the stint at I2R, he moved on to Zuellig Pharma where he took on the role of Chief Data Scientist and led the development of healthcare data capabilities for pharma stakeholders.
Dr. Wee sits on the scientific advisory boards of several technology companies in cybersecurity, medtech and healthtech, and speaks regularly at international conferences in artificial intelligence, data and healthcare. He was previously the President of the Association for Medical and Bio-informatics Singapore (AMBIS), and the current vice-chair of the Chinese-American Pharmaceutical Society (CABS) Singapore chapter. He received his Ph.D. in Computational Biology and Machine Learning from the National University of Singapore. He is also an Associate Faculty at the Singapore University of Social Sciences, and runs a research program in artificial intelligence for cancer genetics.